Zhang Yuanxin, Qin Xiusen, Luo Rui, Wang Hui, Wang Huaiming, Luo Hongzhi
Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Front Oncol. 2022 Jun 20;12:885504. doi: 10.3389/fonc.2022.885504. eCollection 2022.
Early detection of synchronous colorectal peritoneal metastases (CPMs) is difficult due to the absence of typical symptoms and the low accuracy of imaging examinations. Increasing the knowledge of the risk factors for synchronous CPM may be essential for early diagnosis and improving their management. This study aimed to identify the risk factors for synchronous CPM.
The study was registered at PROSPERO (CRD42020198548). The PubMed, Embase and Cochrane Library databases were searched for studies comparing the clinicopathological and molecular features between patients with or without synchronous CPM. The pooled data were assessed by a random-effects model.
Twenty-five studies were included. A synchronous CPM was positively associated with female sex (OR 1.299; 1.118 to 1.509; P = 0.001), PROK1/PROKR2-positivity (OR 2.244; 1.031 to 4.884; P = 0.042), right-sided colon cancer (OR 2.468; 2.050 to 2.970; P < 0.001), poorly differentiated grade (OR 2.560; 1.537 to 4.265; P < 0.001), BRAF mutation (OR 2.586; 1.674 to 3.994; P < 0.001), mucinous adenocarcinoma (OR 3.565; 2.095 to 6.064; P < 0.001), signet-ring cell carcinoma (OR 4.480; 1.836 to 10.933; P = 0.001), N1-2 (OR 5.665; 3.628 to 8.848; P < 0.001), T4 (OR 12.331; 7.734 to 19.660; P < 0.001) and elevated serum CA19-9 (OR 12.868; 5.196 to 31.867; P < 0.001).
These evidence-based risk factors are indicators that could predict the presence of synchronous CPMs and can improve their management.
www.crd.york.ac.uk/prospero, identifier: CRD42020198548.
由于缺乏典型症状且影像学检查准确性较低,同步性结直肠腹膜转移(CPM)的早期检测较为困难。增加对同步性CPM危险因素的认识可能对早期诊断及改善其治疗至关重要。本研究旨在确定同步性CPM的危险因素。
该研究已在PROSPERO(CRD42020198548)注册。检索了PubMed、Embase和Cochrane图书馆数据库,以查找比较有或无同步性CPM患者的临床病理和分子特征的研究。采用随机效应模型评估汇总数据。
纳入了25项研究。同步性CPM与女性(比值比[OR]1.299;95%置信区间[CI]1.118至1.509;P = 0.001)、PROK1/PROKR2阳性(OR 2.244;95%CI 1.031至4.884;P = 0.042)、右半结肠癌(OR 2.468;95%CI 2.050至2.970;P < 0.001)、低分化分级(OR 2.560;95%CI 1.537至4.265;P < 0.001)、BRAF突变(OR 2.586;95%CI 1.674至3.994;P < 0.001)、黏液腺癌(OR 3.565;95%CI 2.